| Schedule of Changes in Fair Value of Outstanding Warrant and Tranche Liabilities |
The following tables summarize the changes in fair value of our outstanding warrant liabilities, contingent earnout liability and revenue base redemption liability for the six months ended June 30, 2026: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Warrant Liabilities | | Fair Value at
December 31,
2025 | | Change in
Fair Value
(Gains) Losses | | Issuances
(Settlements) | | | | Fair Value at
June 30,
2026 | | Public Warrants - Level 1 | | $ | 2,908 | | | $ | (1,506) | | | $ | — | | | | | $ | 1,402 | | | Private Placement Warrants - Level 2 | | $ | 7,352 | | | $ | (3,809) | | | $ | — | | | | | $ | 3,543 | | | Working Capital Warrants - Level 2 | | $ | 1,660 | | | $ | (860) | | | $ | — | | | | | $ | 800 | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Level 3 Liabilities | | Fair Value at
December 31,
2025 | | Change in
Fair Value
(Gains) Losses | | Issuances
(Settlements) | | | | | | Fair Value at
June 30,
2026 | | Contingent earnout liability | | $ | 10,144 | | | $ | (6,406) | | | $ | — | | | | | | | $ | 3,738 | | | | | | | | | | | | | | | | OrbiMed Warrant liability | | $ | 972 | | | $ | (400) | | | $ | — | | | | | | | $ | 572 | | | Revenue base redemption liability | | $ | 383 | | | $ | 106 | | | $ | — | | | | | | | $ | 489 | |
The following tables summarize the changes in fair value of our outstanding warrant liabilities, contingent earnout liability, SEPA liability and revenue base redemption liability for the six months ended June 30, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Warrant Liabilities | | Fair Value at
December 31,
2024 | | Change in
Fair Value
(Gains) Losses | | Issuances
(Settlements) | | | | Fair Value at
June 30,
2025 | | Public Warrants - Level 1 | | $ | 1,927 | | | $ | 333 | | | $ | — | | | | | $ | 2,260 | | | Private Placement Warrants - Level 2 | | $ | 4,872 | | | $ | 841 | | | $ | — | | | | | $ | 5,713 | | | Working Capital Warrants - Level 2 | | $ | 1,100 | | | $ | 190 | | | $ | — | | | | | $ | 1,290 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Level 3 Liabilities | | Fair Value at
December 31,
2024 | | Change in
Fair Value
(Gains) Losses | | Issuances
(Settlements) | | | | | | Fair Value at
June 30,
2025 | | Contingent earnout liability | | $ | 7,401 | | | $ | 121 | | | $ | — | | | | | | | $ | 7,522 | | | SEPA liability | | $ | 55 | | | $ | (52) | | | $ | — | | | | | | | $ | 3 | | | OrbiMed Warrant liability | | $ | 362 | | | $ | 3 | | | $ | 366 | | | | | | | $ | 731 | | | Revenue base redemption liability | | $ | 507 | | | $ | (149) | | | $ | — | | | | | | | $ | 358 | |
|